| abstract |
The invention concerns a pharmaceutical preparation for oral administration containing N-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide or hydrates or solvates thereof, as well as an acid. The invention also concerns a method for producing said preparation, as well as the use thereof for treating and/or preventing diseases mediated by herpesviruses, in particular diseases mediated by Herpesvirus simplex. |